- thickened cerebral cortex / MGI
- increased brain weight / MGI
- abnormal T-helper 2 physiology / MGI
- decreased susceptibility to type I hypersensitivity reaction / MGI
- increased hippocampus volume / MGI
- nervous system phenotype / MGI
- decreased IgG level / MGI
- abnormal B cell morphology / MGI
- decreased susceptibility to parasitic infection / MGI
- decreased IgG1 level / MGI
- abnormal hippocampus morphology / MGI
- abnormal CNS glial cell morphology / MGI
- abnormal neuron morphology / MGI
- abnormal hippocampus CA1 region morphology / MGI
- abnormal hippocampus pyramidal cell morphology / MGI
- increased astrocyte number / MGI
- abnormal microglial cell morphology / MGI
- abnormal corpus callosum morphology / MGI
B6.129-Cd81tm1Lvy/Orl
Status | Available to order |
EMMA ID | EM:04305 |
Citation information | RRID:IMSR_EM:04305 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | B6.129-Cd81tm1Lvy/Orl |
Alternative name | B6-backcrossed Cd81 knockout |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Cd81tm1Lvy |
Gene/Transgene symbol | Cd81 |
Information from provider
Provider | Shoshana Levy |
Provider affiliation | Department of Bioengineering, Stanford University |
Genetic information | Cd81 knockout mice. |
Phenotypic information | Female infertility, resistance to infection by Plasmodium sporozoites, impairment in the immune and nervous systems. |
Breeding history | Female infertility of Cd81 mice was manifested after the 4th backcross to a homozygous background (C57BL/6 and BALB/c). The mice have been backcrossed onto the C57BL/6 background for at least 8 generation. |
References |
|
Homozygous fertile | no |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | yes |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | homozygous C57BL/6J males, wild-type C57BL/6J females |
Stage of embryos | 2-cell |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Common variable immunodeficiency / Orphanet_1572
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- abnormal microglial cell morphology / MGI
- abnormal immune system cell morphology / MGI
- abnormal corpus callosum morphology / MGI
- thickened cerebral cortex / MGI
- abnormal hippocampus morphology / MGI
- abnormal CNS glial cell morphology / MGI
- hypoactivity / MGI
- decreased IgG level / MGI
- increased dopamine level / MGI
- abnormal B cell differentiation / MGI
- increased brain weight / MGI
- abnormal macrophage physiology / MGI
- increased IgM level / MGI
- increased IgA level / MGI
- abnormal neuron morphology / MGI
- nervous system phenotype / MGI
- abnormal nucleus accumbens morphology / MGI
- abnormal B cell morphology / MGI
- decreased B-1 B cell number / MGI
- decreased susceptibility to parasitic infection / MGI
- decreased B cell proliferation / MGI
- abnormal T cell proliferation / MGI
- increased B cell proliferation / MGI
- abnormal T-helper 2 physiology / MGI
- decreased susceptibility to type I hypersensitivity reaction / MGI
- decreased B-1a cell number / MGI
- abnormal hippocampus CA1 region morphology / MGI
- decreased IgG1 level / MGI
- increased IgG3 level / MGI
- impaired behavioral response to cocaine / MGI
- abnormal hippocampus pyramidal cell morphology / MGI
- increased astrocyte number / MGI
- increased hippocampus volume / MGI
Literature references
- Normal lymphocyte development but delayed humoral immune response in CD81-null mice.;Maecker H T, Levy S, ;1997;The Journal of experimental medicine;185;1505-10; 9126932
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).